Credit Suisse’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-149,228
| Closed | -$20.9M | – | 3497 |
|
|
2018
Q4 | $20.9M | Buy |
149,228
+6,090
| +4% | +$853K | 0.02% | 629 |
|
|
2018
Q3 | $24.5M | Buy |
143,138
+14,227
| +11% | +$2.43M | 0.02% | 644 |
|
|
2018
Q2 | $22.4M | Sell |
128,911
-57,080
| -31% | -$9.9M | 0.02% | 654 |
|
|
2018
Q1 | $21.5M | Buy |
185,991
+67,930
| +58% | +$7.84M | 0.02% | 697 |
|
|
2017
Q4 | $9.94M | Buy |
118,061
+47,224
| +67% | +$3.98M | 0.01% | 1048 |
|
|
2017
Q3 | $6.53M | Buy |
70,837
+13,613
| +24% | +$1.25M | 0.01% | 1272 |
|
|
2017
Q2 | $4.59M | Sell |
57,224
-20,438
| -26% | -$1.64M | ﹤0.01% | 1412 |
|
|
2017
Q1 | $3.27M | Buy |
77,662
+35,506
| +84% | +$1.49M | ﹤0.01% | 1687 |
|
|
2016
Q4 | $1.35M | Buy |
+42,156
| New | +$1.35M | ﹤0.01% | 2461 |
|
|
2016
Q3 | – | Sell |
-10,509
| Closed | -$243K | – | 3913 |
|
|
2016
Q2 | $243K | Buy |
+10,509
| New | +$243K | ﹤0.01% | 3479 |
|